Comparison of skin permeation enhancement by 3-l-menthoxypropane-1,2-diol and l-menthol: the permeation of indomethacin and antipyrine through Yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum.
3-l-Menthoxypropane-1,2-diol (MPD) is a derivative of l-menthol, which has an enhancement effect on drug permeation through skin. In this study, the effect of MPD on drug permeation through skin was compared with that of l-menthol. MPD or l-menthol at final concentrations of 3% in 40% ethanol was added to the drugs indomethacin or antipyrine and each mix then applied to Yucatan micropig skin in vitro. Drug concentrations in the skin were higher in the presence of either MPD or l-menthol, however, only l-menthol shortened the lag time of permeation. MPD enhanced the skin permeation of the drugs only by increasing the skin concentration of the drugs. In contrast, l-menthol enhanced the skin permeation of the drugs by increasing both the skin concentration and the diffusion rate in skin. The infrared (IR) spectra and X-ray diffraction patterns of stratum corneum after treatment with MPD did not differ from those of intact stratum corneum. A change in the IR spectra of stratum corneum after treatment with l-menthol was observed at the CH band, and the peaks representative of the lipid structure in the X-ray diffraction patterns decreased in intensity. These results suggest that l-menthol, but not MPD, disrupts the intercellular lipid structure of stratum corneum. Thus, MPD is expected to be a moderate skin permeation enhancer.
Fujii
Makiko
M
Showa Pharmaceutical University, 3-3165 Higashi-Tamagawa-Gakuen, Machida, 194-8543, Tokyo, Japan. fujii@ac.shoyaku.ac.jp
Takeda
Yasuhiro
Y
Yoshida
Minako
M
Utoguchi
Naoki
N
Matsumoto
Mitsuo
M
Watanabe
Yoshiteru
Y
D000287:Administration, Topical; D000818:Animals; D000983:Antipyrine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D066298:In Vitro Techniques; D007213:Indomethacin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008610:Menthol / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D010539:Permeability; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D017550:Spectroscopy, Fourier Transform Infrared; D013552:Swine; D014961:X-Ray Diffraction
C476168:3-menthoxypropane-1,2-diol; D008610:Menthol; D000983:Antipyrine; D007213:Indomethacin